Lymphogranuloma venereum epidemiology and demographics: Difference between revisions
(→Gender) |
(→Age) |
||
| Line 10: | Line 10: | ||
===Age=== | ===Age=== | ||
*LGV is seen in sexually active individuals, ranging from ages 15 to 40 years. | |||
===Gender=== | ===Gender=== | ||
Revision as of 15:20, 18 February 2016
|
Lymphogranuloma venereum Microchapters |
|
Differentiating Lymphogranuloma venereum from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphogranuloma venereum epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Lymphogranuloma venereum epidemiology and demographics |
|
FDA on Lymphogranuloma venereum epidemiology and demographics |
|
CDC on Lymphogranuloma venereum epidemiology and demographics |
|
Lymphogranuloma venereum epidemiology and demographics in the news |
|
Blogs on Lymphogranuloma venereum epidemiology and demographics |
|
Risk calculators and risk factors for Lymphogranuloma venereum epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nate Michalak, B.A.
Overview
While the frequency of LGV infection is thought to be rare in industrialized countries, its identification is not always obvious, so the number of cases of LGV in the United States is unknown. However, outbreaks in the Netherlands and other European countries among men who have sex with men (MSM) have raised concerns about cases of LGV in the U.S.
Epidemiology and Demographics
Incidence
Age
- LGV is seen in sexually active individuals, ranging from ages 15 to 40 years.
Gender
- LGV affects both sexes equally
- Males typically present at earlier stages and females at later stages
- LGV is commonly seen in men who have sex with men (MSM) presenting as proctitis[1]
Race
Developed Countries
Developing Countries
References
- ↑ Ward H, Alexander S, Carder C, Dean G, French P, Ivens D; et al. (2009). "The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study". Sex Transm Infect. 85 (3): 173–5. doi:10.1136/sti.2008.035311. PMC 2683989. PMID 19221105.